High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women

被引:56
|
作者
Ravn, P
Rix, M
Andreassen, H
Clemmesen, B
Bidstrup, M
Gunnes, M
机构
[1] ROSKILDE CTY HOSP KOGE,DEPT INTERNAL MED,ROSKILDE,DENMARK
[2] CTR CLIN OSTEOPOROSIS RES,HAUGESUND,NORWAY
关键词
tiludronate; postmenopausal osteoporosis; urinary CrossLaps; osteocalcin; bone mineral density; spinal fracture; osteoporosis;
D O I
10.1007/s002239900225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis, Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm(2), and 278 women had a BMD below 0.860 g/cm2. Spinal fracture was diagnosed from lateral spine X-ray studies and defined as at least 20% height reduction (wedge, compression, or endplate fracture) in at least one vertebra (T4-L4), Bone resorption was assessed by measurement of the urinary excretion of type I collagen degradation products by the CrossLapsTM enzyme-linked immunoassay (ELISA). Bone formation was assessed by ELISA measurement of the N-terminal-midfragment as well as the intact serum osteocalcin (OCN-MID), thus omitting the influence of the instability of osteocalcin caused by the labile 6 amino acid C-terminal sequence. The women were divided into groups with high or low bone turnover according to the concentrations of urinary CrossLapsTM or OCN-MID. Women in the quartiles with the highest concentrations of CrossLaps [519 +/- 119 mu g/mmol (SD)] or OCN-MID [44.6 +/- 7.5 ng/ml (SD)] had 10-16% lower spinal BMD compared with women in the lowest quartiles (CrossLaps 170 +/- 48 mu g/mmol (SD), and OCN-MID [22.1 +/- 3.0 ng/ml (SD)] (P < 0.0004). The prevalences of spinal fracture were 25 to 29% in the lowest quartiles, whereas the prevalences in the highest quartiles were almost double-53-54% (P < 0.006). If the women were subgrouped according to spinal BMD and prevalence of spinal fracture, corresponding results were found. Women with a BMD less than 0.860 g/cm(2), without or with spinal fracture (n = 136 and n = 142), had 36-43% higher concentration of CrossLaps (P = 0.0001) and 11-15% higher concentration of OCN-MID (P < 0.02), as compared with women with a BMD above 0.860 g/cm(2) and no spinal fracture (n = 84). In conclusion, the results indicate a strong association among high bone turnover, low bone mass, and prevalence of spinal fracture, which supports the theory that high bone turnover is a risk factor for spinal fracture and osteoporosis.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [21] The response in spinal bone mass to Tibolone treatment is related to bone turnover in elderly women
    Bjarnason, NH
    Bjarnason, K
    Hassager, C
    Christiansen, C
    BONE, 1997, 20 (02) : 151 - 155
  • [22] Bone turnover markers in Spanish postmenopausal women The Camargo cohort study
    Martinez, Josefina
    Olmos, Jose M.
    Hernandez, Jose L.
    Pinedo, Gabriel
    Llorca, Javier
    Obregon, Eduardo
    Valero, Carmen
    Gonzalez-Macias, Jesus
    CLINICA CHIMICA ACTA, 2009, 409 (1-2) : 70 - 74
  • [23] Denosumab in treatment-naive and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Efstathiadou, Zoe A.
    Sauvidis, Matthaios
    Sakellariou, Grigorios T.
    Papatheoclorou, Athanasios
    Kokkoris, Panagiotis
    Makras, Polyzois
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (10): : 1291 - 1297
  • [24] Association between sclerostin, serum bone turnover markers and bone density in postmenopausal women with fragility fracture
    Zou, Jian
    Li, Xiaolin
    Yang, Fan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 12984 - 12991
  • [25] Changes in Cytokines, Biomarkers of Bone Turnover and Hormones Are Associated With Bone Loss in Postmenopausal Indian Women
    Desai, Meena
    Khatkhatay, Mohammed Ikram
    Taskar, Vijaya
    Ansari, Zakiya
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 10 (01) : 399 - 403
  • [26] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude Laurent
    Brown, Jacques P.
    Lillestol, Michael
    Siddhanti, Suresh
    Man, Hoi-Shen
    Martin, Javier San
    Bone, Henry G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) : 72 - 81
  • [27] Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
    Brown, Jacques P.
    Prince, Richard L.
    Deal, Chad
    Recker, Robert R.
    Kiel, Douglas P.
    de Gregorio, Luiz H.
    Hadji, Peyman
    Hofbauer, Lorenz C.
    Alvaro-Gracia, Jose M.
    Wang, Huei
    Austin, Matthew
    Wagman, Rachel B.
    Newmark, Richard
    Libanati, Cesar
    Martin, Javier San
    Bone, Henry G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (01) : 153 - 161
  • [28] Utility of laboratory tests in evaluation of fracture risk and in differential diagnostics of low bone mass in asymptomatic postmenopausal women
    Walicka, Magdalena
    Marcinowska-Suchowierska, Ewa
    ENDOKRYNOLOGIA POLSKA, 2009, 60 (02) : 88 - 96
  • [29] Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: A prospective study of bone mineral density and bone turnover rate
    Earnshaw, SA
    Cawte, SA
    Worley, A
    Hosking, DJ
    OSTEOPOROSIS INTERNATIONAL, 1998, 8 (01) : 53 - 60
  • [30] Associations of lipoproteins with bone mass in postmenopausal women
    Skripnikova, I. A.
    Abirova, E. S.
    Alyasova, P. A.
    Alikhanova, N. A.
    Khudyakov, M. B.
    Vygodin, V. A.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (01) : 82 - 88